276 related articles for article (PubMed ID: 28724746)
1. TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy.
Lai DW; Lin KH; Sheu WH; Lee MR; Chen CY; Lee WJ; Hung YW; Shen CC; Chung TJ; Liu SH; Sheu ML
Circ Res; 2017 Sep; 121(6):e37-e52. PubMed ID: 28724746
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential of Tpl2 (Tumor Progression Locus 2) Inhibition on Diabetic Vasculopathy Through the Blockage of the Inflammasome Complex.
Sheu WH; Lin KH; Wang JS; Lai DW; Lee WJ; Lin FY; Chen PH; Chen CH; Yeh HY; Wu SM; Shen CC; Lee MR; Liu SH; Sheu ML
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e46-e62. PubMed ID: 33176446
[TBL] [Abstract][Full Text] [Related]
3. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
4. Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes.
Chen Y; Wang JJ; Li J; Hosoya KI; Ratan R; Townes T; Zhang SX
Diabetologia; 2012 Sep; 55(9):2533-45. PubMed ID: 22660795
[TBL] [Abstract][Full Text] [Related]
5. Loss of X-box binding protein 1 in Müller cells augments retinal inflammation in a mouse model of diabetes.
Yang J; Chen C; McLaughlin T; Wang Y; Le YZ; Wang JJ; Zhang SX
Diabetologia; 2019 Mar; 62(3):531-543. PubMed ID: 30612139
[TBL] [Abstract][Full Text] [Related]
6. Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.
Lee WJ; Lan KH; Chou CT; Yi YC; Chen WC; Pan HC; Peng YC; Wang KB; Chen YC; Chao TH; Tien HR; Sheu WH; Sheu ML
Neoplasia; 2013 Sep; 15(9):1036-48. PubMed ID: 24027429
[TBL] [Abstract][Full Text] [Related]
7. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.
Murata T; Nagai R; Ishibashi T; Inomuta H; Ikeda K; Horiuchi S
Diabetologia; 1997 Jul; 40(7):764-9. PubMed ID: 9243096
[TBL] [Abstract][Full Text] [Related]
8. Role of endoplasmic reticulum stress in 12/15-lipoxygenase-induced retinal microvascular dysfunction in a mouse model of diabetic retinopathy.
Elmasry K; Ibrahim AS; Saleh H; Elsherbiny N; Elshafey S; Hussein KA; Al-Shabrawey M
Diabetologia; 2018 May; 61(5):1220-1232. PubMed ID: 29468369
[TBL] [Abstract][Full Text] [Related]
9. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
[TBL] [Abstract][Full Text] [Related]
10. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
[TBL] [Abstract][Full Text] [Related]
11. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
13. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
[TBL] [Abstract][Full Text] [Related]
14. Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell-derived inflammatory cytokine production in diabetes.
Zhong Y; Li J; Chen Y; Wang JJ; Ratan R; Zhang SX
Diabetes; 2012 Feb; 61(2):492-504. PubMed ID: 22228718
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of 58-kilodalton inhibitor of protein kinase in protecting against diabetic retinopathy via the endoplasmic reticulum stress pathway.
Yang H; Liu R; Cui Z; Chen ZQ; Yan S; Pei H; Li B
Mol Vis; 2011 Jan; 17():78-84. PubMed ID: 21245960
[TBL] [Abstract][Full Text] [Related]
16. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
17. Elevated Nε-(carboxymethyl)lysine is associated with apoptosis of retinal pericytes in streptozotocin-induced diabetic rats.
Kim J; Kim CS; Sohn E; Kim JS
Ophthalmic Res; 2011; 46(2):92-7. PubMed ID: 21273798
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes.
Canning P; Kenny BA; Prise V; Glenn J; Sarker MH; Hudson N; Brandt M; Lopez FJ; Gale D; Luthert PJ; Adamson P; Turowski P; Stitt AW
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7213-8. PubMed ID: 27298369
[TBL] [Abstract][Full Text] [Related]
20. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
